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Abstract--Galactokinase activity is reduced in 12 independent clones of 
Chinese hamster ovary cells resistant to 2-deoxygalactose. The frequency 
of  resistant colonies is increased with chemical mutagens. The resistant 
phenotype is stable in the absence of  selection. There is an inverse cor- 
relation between the levels o f  galactokinase activity and the cloning 
efficiency in deoxygalactose. Cells with high resistance have 1% or less o f  
the enzyme activity observed in the parental cells; while cells with low 
resistance have 10-30% galactokinase activity. Studies with tetraploid 
hybrid cells reveal that resistance to deoxygalactose is a recessive trait 
and that cells with high resistance do not complement those with low 
resistance. In cell lines with low resistance, the K~, for galactose, Kz for 
deoxygalactose, K~, for ATP, and thermolability were not significantly al- 
tered compared to sensitive parental cells. Although the possibility of  mu- 
tation at the structural gene locus has not been ruled out, the reduced 
enzyme activity may also be due to mutation at a regulatory site which af- 
fects the number of  galactokinase molecules per cell. 
INTRODUCTION 
Chinese hamster ovary (CHO) cells which are resistant to 2- 
deoxygalactose (DGA) have been isolated in order to obtain cells with a 
defect in galactose transport or metabolism (Leloir pathway). 
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Growth of CHO K1 is inhibited by the galactose analog 2-deoxygalactose 
in the presence of glucose. This inhibition is reversed by galactose, indi- 
cating that the action of the analog is specific for galactose-metabolizing 
enzymes. 
Alper and Ames (1) have used DGA to select for mutants in 
Salmonella typhimurium which are deleted for galactokinase, UDPG epi- 
merase, and galactose-l-phosphate uridylyltransferase. DGA has also 
been used to select for galactose permease mutants in S. typhimurium (2). 
While this work was in progress, Thirion et al. (3) reported using DGA to 
isolate Chinese hamster lung cells with a defect in galactokinase. In this 
paper, we describe the isolation, and genetic and biochemical characteri- 
zation of deoxygalactose-resistant cells (Dga R) from CHO K1. All 
resistant clones have reduced levels of galactokinase, which also 
catalyzes the ATP phosphorylation of deoxygalactose to deoxygalactose- 
1-phosphate (DGA-l-P) (3). A preliminary report of this work has ap- 
peared (4). 
M A T E R I A L S  A N D  M E T H O D S  
Cell Lines and Cell Culture. Cells were grown in modified Eagle's 
minimum essential medium (5) (Gibco or K.C.) containing Earle's salts, 
hypoxanthine (H), 37/zM; thymidine (T), 21/zM; uridine (U), 21 ~M; 1 
mM pyruvate; 1.5 times the normal levels of vitamins and essential amino 
acids; and 2 times nonessential amino acids, with 5% fetal calf serum 
(Gibco or K.C.) for monolayer growth and 10% serum for suspension cul- 
ture. For cell culture 17.9 mM NaHCO3 and 8.3 mM NaC1 were added to 
the growth media; for plating experiments, 11.9 mM N a H C Q  and 14.3 
mM NaCI were added. Serum dialyzed by ultrafiltration with an Amicon 
UM 10 filter was used in medium lacking proline, medium containing 6- 
"thioguanine, or in medium where 14 mM galactose was substituted for 
glucose. HAT medium contained 3.2/zM aminopterin (A), hypoxanthine 
and thymidine as above. Cells were grown at 37~ in a humid atmosphere 
of 5% CO~ in air. 
CHO K1 (American Type Culture Collection), which is auxotrophic 
for proline (Pro- Gat + Dga s TGS), and a subclone, CHO K1-T4, were 
3Abbreviations used: Uridine diphosphate glucose (UDPG); uridine diphosphate galactose 
(UDP-Gal). Enzymes: galactokinase (EC 2.7.1.6); UDP-glucose: galactose-l-phosphate 
ufidylyltransferase (EC 2.7.7.12); UDP-glucose 4'-epimerase (EC 5.1.3.2). 
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used to isolate Dga R Pro-  Gat + TG s cells. Gat-  Pro + Dga s, referred to as 
Gat - ,  was kindly sent to us by Dr. Larry  Thompson.  Gat - ,  originally 
isolated from CHO-S by McBurney  and Whitmore (6) and called AUX 
B I - ,  is auxotrophic for glycine, adenosine,  and thymidine and lacks 
folylpolyglutamate synthetase (7). Dga R 27 TG R Pro + cells were derived 
from Dga R 27 without mutagenesis after successively selecting for 
thioguanine resistance (TG R) in 60 /xM thioguanine (no HUT)  and for 
Pro + in medium without proline at 10 "~ cells/100-mm petri dish. 
Mutagenesis and Plating Efficiency. Cells growing exponentially in 
monolayer  or suspension culture were treated with N-methyl-N'-nitro-N- 
nitrosoguanidine (MNNG),  I/xg/ml,  for 5 h or with ethyl methanesulfo- 
nate (EMS), 100-400/xg/ml for 16 h. After t reatment,  cells were washed, 
grown, and transferred when necessary in complete media for 6-11 days 
to allow for expression of the phenotype (reviewed in 8). Resistant cells 
were selected in complete media containing 30 or 60 mM DGA after re- 
plating 10 ~ cells/60 mm dish or 15 mM DGA at 104 cells/dish for 10-14 
days. Resistant cell lines Dga R 1 to 26 were selected using 2- 
deoxygalactose purchased from Sigma which contained traces of 
galactose. Dga R 27 to 40 were isolated using the purer  Aldrich DGA. 
The relative plating efficiency in DGA expressed as a percent  is 100 
times the number of colonies or cells in deoxygalactose divided by ' the  
number of colonies or ceils without deoxygalactose.  Colonies were fixed 
with 12% formaldehyde and stained with 0.1% crystal violet. 
Cell Hybridization. Dga R Gat + Pro-  cells, 5 • 105 cells/35-mm plate, 
were fused with Dga s Gat-  Pro + cells, 5 • l0 s cells/35-mm plate, using 
45% polyethylene glycol (9). ,As a control,  two sensitive cell lines, 
Dga s Gat -  Pro + and CHO K 1 (Dga s Gat + Pro- ) ,  were also fused. After 
19-24 h in nonselective medium, fused cells were replated at 103 and 104 
cells/60-mm dish in selective medium lacking proline, adenosine,  and thy- 
midine. Only hybrid clones (denoted as K 1 • Gat -  or Dga ~ __ • Ga t - )  
which were Gat + Pro + could grow in the selective medium. 
Dga R 27 Pro + TG R cells were fused with Dga R 24 Pro-  TG s or with 
Dga R 23 Pro-  TG s, and the resulting hybrid cells (TG s Pro +, denoted as 
Dga R __ • Dga R 27) were selected in HAT medium lacking proline. 
Resistance to thioguanine results from an X-linked recessive mutation 
yielding very low levels of hypoxanthine guanine phosphoribosyl-  
transferase (10-14). TG R cells do not grow in HAT medium while 
TG ~ x TG s hybrid cells and TG s cells do (13, 14). 
No revertants  were observed among the unfused cell populations 
when 3 • 10 5 parental cells were plated in selective medium. Hybrid cell 
colonies were isolated, grown in selective medium, and five or more 
hybrid clones from each fusion combination were tested in medium with 
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and without 6 mM DGA at 200-500 cells/plate. The karyotype of each 
hybrid clone was determined by harvesting exponentially growing cells, 
washing with 0.56% KC1 and then with fixative solution (acetic acid/meth- 
anol, 1:3). Slides were prepared, stained with Giemsa, and 20 representa- 
tive chromosome spreads were counted. 
Enzyme Assays. Cell extracts for galactokinase assays were prepared 
at 4~ as follows. Cells, 30 x 106, were washed with 0.9% NaC1, resus- 
pended in 0.5 ml of buffer containing 0.01 M KPi, pH 6.7; 1 mM EDTA; 
0.5 mM dithiothreitol; sonicated at intervals for a total of 30 sec, and cen- 
trifuged at 17,400g for 20 min. The supernatant solution was passed 
through a column, 1 x 3.8 cm, of Sephadex G50 and eluted in the same 
buffer. After aliquots were taken for protein determination, the 
dithiothreitol concentration was adjusted to 2 mM. EDTA was omitted for 
ATP kinetic studies. For epimerase and transferase assays, the buffer was 
the same except the pH was 7.4 and extracts were assayed without 
Sephadex gel filtration. Protein was determined by the method of Lowry 
(15). 
The procedure of Sherman and Adler (16) was modified to assay 
galactokinase. [ 1-14 C]Galactose was incubated with ATP and hexokinase 
and passed over a column of DEAE 32 to remove any contaminating hex- 
oses before use in the assay (17). In assay A, which was used for kinetic 
studies, the reaction mixture contained 0.2 M Tris-C1, pH 7.8, 22~ 5 mM 
MgC12; 5 mM NaF; 6 mM ATP; 5 mM dithiothreitol; [1-14C]D-galactose 
(New England Nuclear), 0.54/xCi/ml; 0.4 mM galactose. Assay B was the 
same except for the concentrations of MgC12, 2 mM; ATP, 2 mM; 
galactose, 0.2 mM; and [1J4C]galactose, 1/xCi/ml. The reaction mixture 
was incubated for 30 rain at 37~ and terminated by spotting three 25- or 
30-/xl aliquots on 1.5-cm squares of DEAE paper (Whatman DE 81) and 
dropping immediately into 300 ml of water. Papers were washed three 
times with water, dried, and counted in toluene containing 0.1 g POPOP 
and 5 g PPO per liter. The assay was linear with time and enzyme 
concentration at all galactose and ATP concentrations used. 
UDPG epimerase was assayed at 37~ as described previously (17), 
except that 0.1 M glycylglycine, pH 8.7, and 1 mM UDP-Gal were used. 
Galactose-l-phosphate uridylyltransferase was assayed at 37~ by a 
procedure similar to that of Mayes and Hansen (18). The reference and 
sample cuvettes contained 0.1 M glycylglycine, pH 8.7; 1 mM MgC12; 5 
mM dithiothreitol; 1 mM NADP; 6/zM glucose-l,6-diphosphate; 0.5 mM 
UDPG; 0.1 units of phosphoglucomutase (Sigma); 0.1 units of glucose-6- 
phosphate dehydrogenase (Type VII, Sigma); 0.005 units of 6-phospho- 
gluconic acid dehydrogenase (Sigma); and extract in a final volume of 1 
ml. The reaction was intiated by adding galactose-1-phosphate, 0.65 mM, 
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to the sample cuvette. The increase at 340 nm was followed. The blank 
reaction without extract was subtracted. 
RESULTS 
The frequency of colonies resistant to 2-deoxygalactose was 
increased by treatment with chemical mutagens (Table 1). The average 
spontaneous frequency of resistant colonies was 0.6 x 106, whereas the 
frequency induced by MNNG was 8.7 x 106. As the concentration of 
EMS was increased, the frequency of resistant colonies increased from 4 
to 38 • 106. The resistant phenotype was stable after repeated cloning 
and continuous growth in medium without deoxygalactose for seven 
months. These results suggest that the resistant clones arose from gene 
mutation and not adaptation. 
The concentration of DGA needed to inhibit growth of CHO K1 
varied with the number of cells plated (Fig. 1). For example, 6 mM DGA 
completely inhibited growth of CHO K 1 when a low density of cells were 
plated (200-500 cells/60-mm plate). However, the relative number of cells 
in DGA compared to media without DGA was 1% when 10 ~ cells were 
plated and 13% when 8 • l0 s cells were plated in 6 mM DGA. For this 
reason, plating experiments with sensitive and resistant cell lines in DGA 
were performed at low cell density. 
When CHO K1 was plated at 200 cells/60-mm dish in 6 mM DGA, 2 
mM galactose reversed the plating efficiency in DGA from 0% to 90% of 
that in media without the analog. CHO K1 plated with an efficiency of 
only 5-7% in 6 mM DGA when 55 mM glucose, mannose, or fructose 
were added. Similarly, uridine, 0.12 raM, did not increase the plating 
efficiency in DGA. 
Among 19 independently isolated clones, high and low levels of 
resistance to DGA were observed (Fig. 1). Most clones, such as Dga R 3, 
Table 1. Induction of Mutants  Resis tant  to 2-Deoxygalactose  in CHO Cells 
Observed colonies/~ Mutat ion f requency 
Exper iment  Mutagen cells plated per 106 survivors  a 
A None  5/6.4 • 106 1.04 
M N N G  (1/zg/ml) 19/3.8 • 106 8.7 
EMS (400/xg/ml) 54/3.7 • 106 30.1 
B None  1/4 x 106 0.26 
EMS (100/.Lg/ml) 2/1 • 106 4.0 
EMS (200/zg/ml) 19/1 • 106 38.0 
EMS (400/xg/ml) 14/1 • 106 28.0 
a Corrected for plating efficiency without DGA. 
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Fig. 1. Plating efficiency of sensit ive and resis tant  cell lines in different concentra t ions  of 
deoxygalactose.  Upper  panel  (high cell density): C HO K1 was inoculated at 8 • 105 
cells/60-mm plate, ~x; and at 1 x 105 cells/60-mm plate, 9 In media without DGA,  cells were 
removed  with trypsin and counted at confluency (3-5 days);  in media with DGA,  cells were 
counted at 6 -7  days.  These  number s  were used to calculate the relative plating efficiency. 
Lower  panel  (low cell density): ceils were plated at 200-500 cells/60-mm plate and colonies 
were stained and counted after 8-12 days.  o, CHO KI; zx, Dga a 26; m, Dga  R 24; m, Dga a 6; 
V, Dga R 3; I ,  Dga R 8. 
6, 27, were highly resistant to DGA and did not grow on galactose as a 
sole carbon source (Table 2). The plating efficiency of these clones in 6 
mM DGA was 87-100% of that without DGA compared to 0% for CHO 
K1. Three clones, Dga R 23, 24, 26, were isolated which had low resistance 
to DGA and grew on galactose. Dga R 23, 24, 26 plated in 6 mM DGA with 
an efficiency of 10-30% even after successive recloning. 
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Table 2. Properties of Deoxygalactose-Sensitive and -Resistant CHO Cells 
Cell line 
Relative Specific activity c 
plating Growth in 
Mutagen Efficiency a (%) galactose b Kinase Epimerase Transferase 
C H O K I  none <0.13 + 4.17 7.14 3.14 
CHO Kl-T4 none <0.08 + 4.47 7.33 4.33 
DG 3-1 MNNG 100 - 0 6.90 3.29 
DG 6-1 MNNG 87 - 0 7.16 2.44 
DG 8-1 MNNG 100 - 0.02 7.58 1.62 
DG 23-1-1 EMS 14 + 1.07 6.80 3.04 
DG 24-4-3 EMS 30 + 1.40 6.80 3. I8 
DG 26-1 EMS 10 + 0.32 6.95 3.44 
DG 27-1 none 97 - 0 6.35 3.75 
DG 30-1 EMS 89 - 0 7.33 3.79 
DG31-1 MNNG 91 - 0 8.61 4.07 
DG 32-1 EMS 100 - 0 10.59 4.69 
a Plating in (6 mM DGA/0 mM DGA) x 100; 200-500 cells/60-mm dish; 3-4 plates each DGA 
concentration. 
0 1 • 10 ~ cells/60-mm plate in 15 mM galactose. 
c Specific activity in nmol/min/mg protein. Galactokinase was determined with assay A. 
Galactokinase specific activity is reduced in all deoxygalactose- 
resistant cell lines (Table 2). The highly resistant cells had less than 1% of 
the activity observed in CHO K1. Cell lines with /ow resistance had 
7-31% of the galactokinase activity present in the sensitive parental cells. 
When sensitive and resistant cell extracts were mixed, the galactokinase 
activity of the sensitive cells was not inhibited. Removal of small 
molecules by Sephadex G-50 gel filtration did not restore activity in 
resistant cell extracts. Thus the lack of galactokinase activity in the 
resistant cells was not due to the presence of an inhibitor. UDPG epi- 
merase activity in resistant cell lines is nearly the same or slighly higher 
than in sensitive cells. Galactose-l-P uridylyltransferase activity is also 
not significantly different in Dga ~ cells from that of sensitive cells. Dga • 6 
and Dga ~ 8 have somewhat reduced levels of transferase activity which 
may be due to clonal variation. 
In order to determine if the galactokinase protein is altered in cells 
with low resistance, the kinetic and thermosensitivity properties of the 
enzyme were examined in cell free extracts after Sephadex G-50 gel filtra- 
tion. Dga R 24, Dga R 26, and CHO KI showed the same loss of enzyme 
activity when heat inactivated at 44-51~ for up to 10 rain and then 
assayed at 37~ 
The K,, for galactose and ATP, Ki for deoxygalactose, and Vmax per 
mg of protein were determined from Lineweaver-Burk plots where the 
galactose concentration was varied in the presence of a constant amount 
of the inhibitor analog DGA (Fig. 2). Three of the 4 lines intersect at a 
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Fig. 2. Lineweaver-Burk plot of galactokinase activity in CHO K1 cells. The concentration 
of galactose was varied in the presence of a constant concentration of deoxygalactose (Al- 
drich), e, 0 mM DGA; zx, 5 mM DGA; ~, 10 mM DGA; o, 20 mM DGA. Lines were drawn 
from regression analysis. 
single point on the y axis as expected  for a pure compet i t ive inhibitor of  
galactose.  The small deviation in the fourth line is within the variat ion of 
the radioactive assay.  The Km and V,r, ax were calculated f rom the x and y 
intercepts,  respectively.  The Ks for deoxygalac tose  was calculated f rom 
the x intercept in a secondary plot of  the slopes f rom the Lineweaver-  
Burk plot versus the inhibitor concentrat ion (19) (Fig. 3). Similar data 
were obtained for Dga R 23, 24, and 26 and are summarized  in Table 3. The 
gmax per mg of protein is 24% of the average value for CHO K1 and T4 
with Dga R 23; 31% with Dga R 24; 7% with Dga R 26. However ,  the Km for 
galactose,  Ks for deoxygalactose ,  and Ka, for ATP were not significantly 
altered in the resistant cells compared  to the sensitive cells. 
Deoxygalac tose  resistant cells were fused with sensitive cells to de- 
termine if resistance is a recessive or dominant  trait. I f  resistance is 
recessive,  these tetraploid hybrid cells are expected  to be sensitive to 
DGA. As a control,  two sensitive cell lines, K 1 and Ga t - ,  were also fused. 
Most K1 • Ga t -  clones showed a plating efficiency in 6 mM DGA from 0 
to 5% of that with no DGA; one unusual hybrid K1 • Ga t -  clone 12 
exhibited an even higher plating of 18.6% (Table 4). Hybr id  clones formed 
from sensitive cells and cells with low resistance,  Dga R 24 • Ga t -  and 
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Fig. 3. Secondary plot of the data from Fig. 2 and other data not shown. DGA concentration 
is plotted versus the slope of the Lineweaver-Burk curves where galactose concentration 
was varied in the presence of a constant concentration of DGA. o, CHO K 1 ; ~, Dga R 23-1-1 ; 
o, Dga R 24-4-3; a, Dga R 26-1. 
Dga  R 23 x G a t - ,  p l a t e d  wi th  an  e f f ic iency  o f  0 - 1 0 %  in 6 m M  D G A .  Wi th  
one  e x c e p t i o n  h y b r i d  c lones  f o r m e d  b e t w e e n  h ighly  r e s i s t an t  cel ls  and  
sens i t ive  ce l ls ,  Dga  R 27 • G a t - ,  e x h i b i t e d  a p la t ing  e f f ic iency  of  3 - 2 0 %  in 
6 m M  D G A .  On  the  bas i s  o f  c o l o n y  s ize  and  p la t ing  ef f ic iency in d i f fe ren t  
c o n c e n t r a t i o n s  o f  D G A  (Fig .  4), h y b r i d s  Dga  R 23 x G a t - ,  Dga  R 
24 • G a t - ,  and  Dga  R 27 x G a t -  w e r e  m o r e  s imi la r  to  the  sens i t ive  con-  
t rol  hyb r id ,  K1 x G a t - ,  t han  to  the i r  r e s i s t an t  d ip lo id  p a r e n t a l  cel ls .  
T h e r e f o r e  we  c o n c l u d e  tha t  D G A  r e s i s t a n c e  is a r e c e s s i v e  t rai t .  
The  h igher  p la t ing  e f f ic iency  o f  Dga  R 23 x G a t - ,  Dga  R 24 x G a t - ,  
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Table 3. Kinetic Properties of 2-Deoxygalactose-Sensitive and -Resistant CHO Cells 
Vmax/protein ~ Galactose Km Deoxygalactose K~ ATP K,~ 
Cell line (nmoles/min/mg) (raM) (raM) (mM) 
CHO K1 5.66 0.147 4.49 0.084 
CHO K1-T4 6.43 0.180 5.08 N.DP 
DG 23-1-1 1.44 0.143 5.28 N.D. 
DG 24-4-3 1.86 0.134 4.73 0.094 
DG 26-I 0.42 0.126 3.52 0.067 
aAssay A was used for the kinetic studies. Vmax was determined from varying galactose 
concentrations. 
b N.D. = not determined. 
D g a  R 27 x G a t - ,  a n d  K1 x G a t -  c l o n e  12 in  D G A  c o m p a r e d  to  t h e  s e n s i -  
t ive  c o n t r o l  K1 x G a t -  c l o n e  1 ( F i g .  4) is  a r e f l e c t i o n  o f  l o w e r  g a l a c t o k i -  
n a s e  a c t i v i t y  in  t h e s e  h y b r i d s  r e l a t i v e  to  K1 x G a t -  c l o n e  1 ( T a b l e  4). 
G a l a c t o k i n a s e  s p e c i f i c  a c t i v i t y  o f  h y b r i d s  f o r m e d  b e t w e e n  D g a  R a n d  G a t -  
ce l l s  a n d  K1 x G a t -  c l o n e  12 w a s  4 8 - 6 2 %  o f  t h a t  o b s e r v e d  w i t h  
K1  • G a t -  c l o n e s  1 a n d  18. W i t h  t h e  e x c e p t i o n  o f  K1  x G a t -  c l o n e  12 
a n d  D g a  R 27 x G a t -  c l o n e  4, t h i s  w a s  t h e  l e v e l  o f  g a l a c t o k i n a s e  a c t i v i t y  
Table 4. Properties of Tetraploid Hybrid Cells 
Chromosome 
number 
Cell line Mean o~ 
Relative Galactokinase b 
plating 
efficiency ~ (%) Spec. act. % 
Gat- 21.0 0.9 <0.05 3.9 
K1 • Gat--1 38.2 1.3 <0.13 3.53 100 
K1 • Gat--18 38.6 2.8 2.0 3.23 100 
K1 • Gat--12 37.4 1.6 18.6 1.89 56 
Dga R 27 • Gat--1 41.3 4.1 20.3 1.62 48 
Dga R 27 • Gat--3 40.3 1.5 8.7 1.73 51 
Dga R 27 x Gat--4 38.9 1.9 66.7 0.19 6 
Dga R 27 x Gat--5 34.3 2.6 3.3 1.92 57 
Dga R 24 x Gat--6 39.6 1.9 5.9 1.98 59 
Dga n 24 • Gat--11 38.0 1.7 6.5 1.92 57 
Dga R 23 • Gat--7 39.9 3.1 0.6 2.10 62 
Dga R 23 • Gat - - l l  40.9 2.1 3.1 2.09 62 
Dga R 24 x Dga R 27-6 39.2 2.9 67.0 0.72 21 
Dga R 24 • Dga R 27-8 40.7 2.9 61.3 0.47 14 
Dga R 23 • Dga a 27-18 38.3 1.6 61.7 0.60 18 
Dga R 23 • Dga R 27-20 40.7 2.0 54.2 0.65 19 
Plating in (6 mM DGA/0 mM DGA) z 100; 200-500 cells/60-mm dish; 3-4 plates each DGA 
concentration. 
Specific activity in nmol/min/mg protein using assay B. The average value of the first two 
hybrid clones in the table was taken as 100%. 
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Fig. 4. Plating of representative diploid and tetraploid clones in DGA at 200-500 cells/60- 
mm dish, 4 plates each DGA concentration. Panel A: u, Dga R 27-1 TG e Pro+; v, Dga R 23-1- 
1 x Dga R 27-1 clone 20; m, Dga R 27-1 x Gat-  clone 1; A, Dga R 23-1-1; ~, Dga R 23-1- 
1 • Gat-  clone 11; o, KI ;  o, K1 x Gat-  clone 1. Panel B: o, Dga R 27-1; v, Dga R 24-4- 
3 x Dga ~ 27-1 clone 8; A, Dga R 24-4-3; u, K1 x Gat-  clone 12; o, Dga R 27-1 x Gat- clone 
1; ~x, Dga R 24-4-3 x Gat-  clone l l ;m,  Gat- .  
expected for coexpression of enzyme activity considering the activity in 
the diploid parental cells. 
Two atypical clones, Dga R 27 x Gat- clone 4 and K 1 x Gat- clone 
12 clearly have a much higher plating efficiency in DGA than other clones 
from these crosses. In both cases, the higher plating corresponded with 
decreased galactokinase activity. It is possible that these particular hy- 
brids have lost a functional wild-type (structural or regulatory) gene for 
galactokinase soon after cell fusion since the selected markers were 
Gat + Pro +. Chromosomal loss, rearrangement, and alteration is increased 
in tetraploid CHO cells (20). Since the frequency of their occurrence is 
high (8-20%), it is unlikely that these unusual clones arose by mutation. If 
the galactokinase gene is functionally hemizygous (see Discussion)in 
DGA-sensitive CHO cells and one wild-type allele is lost or inactivated in 
the tetraploid cell, one would expect K1 x Gat = clone 12 to have about 
50% of the enzyme activity observed in K1 x Gat- clone 1 and Dga R 
27 x Gat- clone 4, about 0%. The observed values of 56% and 6%, 
respectively, are in good agrement with the predicted ones. 
The second series of hybridization experiments involved fusion 
between cells with high DGA resistance and those with low resistance to 
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determine if they complemented each other. If complementation occurs, 
hybrid cells, Dga R 23 x Dga R 27 or Dga R 24 x Dga R 27, would be sensi- 
tive to DGA and plating in DGA would be intermediate between that of 
hybrids formed from the respective resistant cells and sensitive cells 
(Dga a 23 x Gat -  and Dga R 27 x Gat -  or Dga R 24 x Gat and 
Dga R 27 x Gat-).  On the other hand, if complementation does not take 
place, hybrid cells, Dga R 23 • Dga R 27 or Dga R 24 • Dga R 27, would be 
resistant to DGA and plating in DGA would be intermediate between that 
of the respective resistant parents (Dga R 23 and Dga R 27 or Dga R 24 and 
Dga R27). Dga R23 • Dga R27 and Dga R24 x Dga R27 gave large 
colonies in medium containing DGA with a high plating efficiency of 50- 
80% (Table 4). Plating of these hybrids at different concentrations of DGA 
was intermediate between that of the respective resistant parental cells 
(Fig. 4). Galactokinase activity in Dga n 23 x Dga R 27 and Dga R 24 x Dga R 
27 was 14-21% of that observed in the sensitive control hybrids, 
K1 x Gat- clones 1 and 18 (Table 4). From the high plating efficiency in 
DGA and the low galactokinase activity in Dga R 23 x Dga R 27 and Dga R 
24 x Dga n 27, we conclude that cells with high resistance did not comple- 
ment those with low resistance with respect to DGA resistance of in vitro 
galactokinase activity. 
DISCUSSION 
The increased number of resistant cells after treatment with chemical 
mutagens and the stability in the absence of selection suggest that DGA 
resistance arises from gene mutation. Although CHO cells in culture are 
diploid in terms of DNA content, extensive chromosomal rearrangement 
has occurred compared to the Chinese hamster (20). Since so many au- 
tosomal recessive mutants have been isolated in CHO, Siminovitch (21) 
has suggested that CHO may be functionally hemizygous for many au- 
tosomal gene loci due to chromosomal rearrangement. This may be the 
case with DGA resistance. Considering that resistance is recessive, the 
spontaneous frequency, 0.6 x 106, is consistent with a functionally 
hemizygous state in CHO due to X linkage or autosomal rearrangement 
(22). The galactokinase structural gene has been mapped on autosomal 
chromosomes in humans (23), primates (24), and mice (25). 
Galactokinase activity is reduced in all DGA-resistant cell lines 
derived from CHO K 1. Thus, formation of deoxygalactose-1-phosphate is 
implicated in growth inhibition by DGA. In rat ascites hepatoma cells, 
DGA- 1-P represents 99% of the total metabolites of DGA (26). In rat liver, 
UDP-deoxyhexoses are also formed from DGA (27). These studies sug- 
gest that DGA might inhibit growth by depletion of the intracellular pools 
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of inorganic phosphate or uridine. If DGA inhibits cell growth by trapping 
uridine, then uridine or other hexoses, such as glucose, fructose, or man- 
nose, which are metabolized to UDPG and UDPGal might reverse the in- 
hibition. We found that galactose but not glucose, fructose, mannose, or 
uridine reversed the DGA inhibition of growth of CHO cells. Therefore, it 
is likely that DGA primarily inhibits growth because it accumulates as 
DGA-1-P in a reaction catalyzed by galactokinase. This results in the trap- 
ping of inorganic phosphate which is required for energy production by 
glycolysis and oxidative phosphorylation. There are several possible 
reasons why all of our resistant cell lines are defective in galactokinase 
activity and none deficient at other steps: (1) DGA is not metabolized 
further than DGA-1-P; (2) a double mutation is required to significantly af- 
fect activity at other loci; (3) we have examined too few resistant cell 
lines, or (4) our selective conditions are not optimal to detect other types 
of mutations. 
Most interestingly, there is a rough inverse relationship between the 
level ofgalactokinase activity and the plating efficiency in DGA. With one 
exception (Dga R 26), sensitive and resistant cell lines fall into four groups. 
The first group is represented by sensitive cell lines as CHO K 1, T4, Gat-, 
K1 z Gat- clones 1 and 18, which plate with an efficiency of 0-3% in 
DGA and have 65-100% galactokinase activity. The second group (e.g., 
Dga R 23 x Gat-, Dga R 24 x Gat-, Dga R 27 • Gat-, K1 x Gat- clone 
12) is very slightly resistant with a plating efficiency of 1-20% in DGA and 
enzyme activity of 48-62%. The third group is composed of ceils with low 
resistance, as Dga R 23 and Dga R 24, which have a plating efficiency of 14- 
30% in DGA and 24-31% galactokinase activity. The last group (e.g., 
Dga R27, Dga R23 x Dga R27, Dga R24 z Dga R27, Dga R27 x Gat- 
clone 4) is highly resistant with 54-100% plating in DGA and 0-21% 
enzyme activity. It is noteworthy that two atypical hybrid clones, 
K1 x Gat- clone 12 and Dga R 27 x Gat- clone 4, picked at random for 
traits other than resistance, exhibited a higher plating efficiency in DGA 
than other clones from these crosses and simultaneously showed a 
decreased galactokinase activity. This further confirms the inverse rela- 
tionship between DGA resistance and the level ofgalactokinase activity. 
Analysis of DGA resistance and in vitro galactokinase activity in 
Dga R x Dga s hybrid cells show that resistance is a recessive mutation 
and that galactokinase levels are those expected for coexpression of the 
enzyme activity. Cells with high resistance do not complement those with 
low resistance with respect to plating in DGA or galactokinase activity in 
extracts. The lack of complementation indicates that cell lines with high 
and low resistance have mutations in the sa~e cistron affecting galactoki- 
nase activity. Since galactokinase is a simple monomeric protein (28), dif- 
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ferent mutations in the structural gene for this enzyme clearly would not 
complement one another. However, mutation at a regulatory locus affect- 
ing transcription or translation ofgalactokinase is also possible. 
The reduced activity of galactokinase in the Dga R cells could be due 
to a mutation in a regulatory gene or structural gene. A regulatory muta- 
tion affecting transcription, posttranscription, or translation will not 
modify the thermolability or kinetic properties o f  the galactokinase 
enzyme in the resistant cells compared to the sensitive parental cells. 
These properties might be altered in a structural gene mutation (11) or mu- 
tation affecting posttranslational modification of the protein. Although the 
Vmax per mg of protein was reduced in cells with low resistance, the K,,, 
for galactose, K~ for deoxygalactose, K,~, fo r  ATP, and thermolability 
were not significantly altered. Hence, it is possible that the reduced 
enzyme activity is due to a regulatory gene mutation which decreases the 
number of protein molecules per cell. However, a structural gene muta- 
tion which decreased the activity of the protein is not completely ruled 
out. 
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